1 evidence check
Last checked: 4/3/2026
The source does not mention CEPI leveraging pre-pandemic vaccine development investments to accelerate COVID-19 vaccine access for low- and middle-income countries. The source states that CEPI has supported the development of 8 authorized COVID-19 vaccines, not that its COVID-19 portfolio supported the development of 8 authorized vaccines.
Evidence — 1 source, 1 check
Note: The source does not mention CEPI leveraging pre-pandemic vaccine development investments to accelerate COVID-19 vaccine access for low- and middle-income countries. The source states that CEPI has supported the development of 8 authorized COVID-19 vaccines, not that its COVID-19 portfolio supported the development of 8 authorized vaccines.
Debug info
Record type: citation
Record ID: page:coalition-for-epidemic-preparedness-innovations:fn16